Showing results (211-220 of 289) with videos related to
Sort By:
Pageof 29
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 10, 2025
EEG changes induced by dopamine replacement therapy in Parkinson's disease with impulse control disordersJuan Francisco Martín-Rodríguez, Elena Iglesias-Camacho, Francisco J Gómez-Campos, et al.Journal of Clinical Medicine|May 17, 2020
Differences in Results and Related Factors Between Hospital-at-Home Modalities in Catalonia: A Cross-Sectional StudyJorge Arias-de la Torre, Evangelia Anna María Zioga, Lizza Macorigh, et al.Clinical Nuclear Medicine|March 30, 2021
Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the StriatumMiguel A Labrador-Espinosa, Michel J Grothe, Daniel Macías-García, et al.BMC Public Health|January 13, 2009
Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC studyEulàlia Borrell, Mar Rodríguez, Pere Torán, et al.European Journal of Gastroenterology & Hepatology|September 5, 2009
Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in SpainLlorenç Caballería, Guillem Pera, Maria Antònia Auladell, et al.Healthcare (Basel, Switzerland)|August 26, 2022
Associations between Physical Activity Level and Mental Health in the Spanish Population: A Cross-Sectional StudyÁngel Denche-Zamorano, Sabina Barrios-Fernandez, Rafael Gómez-Galán, et al.NPJ Parkinson'S Disease|July 17, 2021
Serum lipid profile among sporadic and familial forms of Parkinson's diseaseDaniel Macías-García, María Teresa Periñán, Laura Muñoz-Delgado, et al.BMC Psychiatry|January 31, 2020
Study protocol of a randomised clinical trial testing whether metacognitive training can improve insight and clinical outcomes in schizophreniaJavier-David Lopez-Morinigo, Verónica González Ruiz-Ruano, Adela Sánchez Escribano Martínez, et al.Journal of Neurology|September 28, 2022
Homocysteine levels, genetic background, and cognitive impairment in Parkinson's diseaseMaría Teresa Periñán, Daniel Macías-García, Silvia Jesús, et al.Molecular Pharmaceutics|June 11, 2016
Combining Stimulus-Triggered Release and Active Targeting Strategies Improves Cytotoxicity of Cytochrome c Nanoparticles in Tumor CellsMoraima Morales-Cruz, Alejandra Cruz-Montañez, Cindy M Figueroa, et al.Pageof 29